Keurig Dr Pepper (KDP)
(Delayed Data from NSDQ)
$32.83 USD
-0.15 (-0.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $32.89 +0.06 (0.18%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.83 USD
-0.15 (-0.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $32.89 +0.06 (0.18%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
Zacks News
Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on its 2020 Strategy, focus on e-commerce growth and brand-management initiatives.
Here's Why Archer Daniels' (ADM) Q1 Earnings May Decline Y/Y
by Zacks Equity Research
Archer Daniels (ADM) witnesses softness in its Carbohydrate Solutions segment, which is likely to weigh on its first-quarter 2019 results. However, its cost-saving efforts are encouraging.
5 Consumer Staples Stocks Set to Beat This Earnings Season
by Zacks Equity Research
Although high input costs are a concern for players in the consumer staples sector, a few are likely to gain from prudent acquisitions, savings and brand augmenting efforts.
Why Is Keurig Dr Pepper (KDP) Up 11.2% Since Last Earnings Report?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons to Add Monster Beverage (MNST) to Your Portfolio
by Zacks Equity Research
Monster Beverage (MNST) is well poised for growth, driven by momentum in the energy drinks business and strong international presence.
Here's What You Must Know About Keurig Dr Pepper (KDP) Stock
by Zacks Equity Research
Keurig Dr Pepper's (KDP) growth strategies like acquisitions and partnerships position it for long-term growth. However, softness in the Coffee Systems business remains a hurdle.
The Zacks Analyst Blog Highlights: NextEra, T-Mobile, Petrobras, Keurig Dr Pepper and United Continental
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NextEra, T-Mobile, Petrobras, Keurig Dr Pepper and United Continental
Top Stock Reports for NextEra Energy, T-Mobile & Petrobras
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy (NEE), T-Mobile (TMUS) and Petrobras (PBR).
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
Keurig Dr Pepper (KDP) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from integration of the merged companies, which is aiding quarterly performance. However, lower realized prices, unfavorable currency and higher costs remain bottlenecks.
Earnings Preview: Keurig Dr Pepper (KDP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Keurig Dr Pepper (KDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
Top Research Reports for Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (MS), Intuitive Surgical, Inc. (ISRG) and Colgate-Palmolive Company (CL).
Will P&G's (PG) Efforts Help Sustain Stock Momentum in 2019?
by Zacks Equity Research
Procter & Gamble (PG) displays momentum, backed by impressive growth strategies and cost-saving efforts to boost margins, which have boosted its top and bottom lines.
Will Monster Beverage's Strategies Cushion the Stock in 2019?
by Zacks Equity Research
Monster Beverage (MNST) witnesses strained margins, owing to higher expenses. However, its solid energy drink category and other efforts are encouraging.
Molson Coors (TAP) Shows Resilience: Stock to Surge in 2019?
by Zacks Equity Research
Molson Coors (TAP) displays momentum backed by focus on cost savings and premiumization of its portfolio, which has boosted its top and bottom lines.
Here's Why You Should Hold on to Keurig Dr Pepper Stock Now
by Zacks Equity Research
Keurig Dr Pepper's (KDP) strong performance in third-quarter 2018 and a promising outlook, alongside its partnerships and acquisition strategy, position it for growth in the future.
Why Is Keurig Dr Pepper (KDP) Down 8.8% Since Last Earnings Report?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper
by Zacks Equity Research
Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper
The Zacks Analyst Blog Highlights: PetroChina, NextEra, Eni, Dr Pepper and Regeneron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PetroChina, NextEra, Eni, Dr Pepper and Regeneron
Buy These 5 Stocks With Sales Growth Amid Volatile Markets
by Zacks Equity Research
A company can improve earnings by controlling costs and maintaining stable revenues. But superior profits can only be generated through steady sales growth.
Top Stock Reports for PetroChina, NextEra & Eni
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including PetroChina (PTR), NextEra (NEE) and Eni (E).
Time to Buy Coca-Cola (KO) Stock Near New All-Time High?
by Benjamin Rains
Should investors consider buying Coca-Cola stock with its shares up 11% over the last month alone?
Keurig Dr Pepper (KDP) Beats on Q3 Earnings, Retains View
by Zacks Equity Research
Keurig Dr Pepper's (KDP) reports third-quarter 2018 results, wherein earnings beat estimates and sales lag. The company remains optimistic about its long-term growth targets.